第一工業製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 化学 | 4461/E00885 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/05/10 | 日証協 | 106,232株 | -4.15% | 64,521株 | -46.52% | 250,824株 | -0.71% | 48,710株 | +93.3% |
2019/04/26 | 日証協 | 110,828株 | +11.82% | 120,640株 | -5.55% | 252,624株 | -5.82% | 25,199株 | -60.63% |
2019/04/19 | 日証協 | 99,114株 | -13.69% | 127,733株 | +53.83% | 268,224株 | -2.44% | 63,999株 | +164.45% |
2019/04/12 | 日証協 | 114,841株 | -6.95% | 83,036株 | +1.29% | 274,923株 | -7.03% | 24,201株 | -20.13% |
2019/04/05 | 日証協 | 123,417株 | +19.36% | 81,977株 | -28.28% | 295,725株 | +3.04% | 30,300株 | -60.46% |
2019/03/29 | 日証協 | 103,400株 | +51.17% | 114,300株 | +86.46% | 286,998株 | +5.97% | 76,624株 | +68.78% |
2019/03/22 | 日証協 | 68,401株 | +49.67% | 61,301株 | +133.84% | 270,823株 | +11.21% | 45,400株 | +70.04% |
2019/03/15 | 日証協 | 45,701株 | -20.93% | 26,215株 | -36.68% | 243,523株 | -3.03% | 26,700株 | +38.33% |
2019/03/08 | 日証協 | 57,799株 | -10.39% | 41,398株 | -43.3% | 251,121株 | -6.97% | 19,302株 | -43.25% |
2019/03/01 | 日証協 | 64,501株 | +115% | 73,015株 | +60.98% | 269,921株 | +3.9% | 34,014株 | -26.22% |
2019/02/22 | 日証協 | 30,000株 | -14.29% | 45,357株 | +66.75% | 259,793株 | +8.33% | 46,100株 | +92.08% |
2019/02/15 | 日証協 | 35,000株 | +72.41% | 27,200株 | +31.57% | 239,821株 | +8.47% | 24,001株 | -70.78% |
2019/02/08 | 日証協 | 20,300株 | -7.73% | 20,673株 | +54.28% | 221,096株 | +32.62% | 82,132株 | +633.39% |
2019/02/01 | 日証協 | 22,000株 | -61.08% | 13,400株 | +8.93% | 166,720株 | -15.75% | 11,199株 | -58.52% |
2019/01/25 | 日証協 | 56,530株 | -31.69% | 12,301株 | -35.6% | 197,898株 | -4.35% | 26,998株 | +77.63% |
2019/01/18 | 日証協 | 82,758株 | -10.97% | 19,100株 | -73.74% | 206,898株 | +1.71% | 15,199株 | -18.73% |
2019/01/11 | 日証協 | 92,959株 | -11.32% | 72,729株 | +159.5% | 203,423株 | -5.92% | 18,701株 | +779.63% |
2019/01/04 | 日証協 | 104,827株 | -4.79% | 28,027株 | -44.94% | 216,222株 | -0.39% | 2,126株 | -92.29% |
2018/12/28 | 日証協 | 110,098株 | +6.24% | 50,901株 | -27.08% | 217,066株 | +3.06% | 27,574株 | -51.54% |
※株式分割は考慮していませんのでご注意ください。
Page Top